CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis

Digestive Diseases and Sciences

Volumn 53, Issue 3, 2008, Pages 657-663

  Okuda, Toshimitsu ^a   Yoshida, Norimasa ^a   Takagi, Tomohisa ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Ichikawa, Hiroshi ^a   Naito, Yuji ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Angiotensin II type I receptor antagonist; Indomethacin; Intestinal injury

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CANDESARTAN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INDOMETACIN; MYELOPEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE MUCOSA; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZIMIDAZOLES; CHEMOKINE CXCL1; ENTERITIS; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; PEPTIC ULCER; PEROXIDASE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 40049105104     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9931-0     Document Type: Article

References (40)

1. Robert A, Asano T (1977) Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 14:333-341
2. Fang WF, Broughton A, Jacobson ED (1977) Indomethacin-induced intestinal inflammation. Am J Dig Dis 22:749-760
3. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ (1987) Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93:480-489
4. Whittle BJ (1981) Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94-98
5. Weissenborn U, Maedge S, Buettner D, Sewing KF (1985) Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 30:32-39
6. Redfern JS, Blair AJ 3rd, Lee E, Feldman M (1987) Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2. Gastroenterology 93:744-752
7. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641-662
8. Whittle BJ, Laszlo F, Evans SM, Moncada S (1995) Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 116:2286-2290
9. Basivireddy J, Jacob M, Ramamoorthy P, Pulimood AB, Balasubramanian KA (2003) Indomethacin-induced free radical-mediated changes in the intestinal brush border membranes. Biochem Pharmacol 65(4):683-695
10. Navar LG., Carmines PK, Huang WC, Mitchell KD (1987) The tubular effects of angiotensin II. Kidney Int Suppl 20:S81-S88
11. Dzau VJ, Gibbons GH, Pratt RE (1991) Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18:II100-II105
12. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J (2001) Role of the renin-angiotensin system in vascular disease: expanding the field. Hypertension 38:1382-1387
13. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in culutured vascular smooth muscle cells. Circ Res. 74:1141-1148
14. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 97:1916-1923
15. Good JM, Nihoyannopoulos P, Ghatei MA, Crossman D, Bloom SR, Clark P, Oakley CM, Cleland JG (1994) Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II. Eur Heart J 15:1634-1640
16. Sigurdsson A, Held P, Swedberg K (1993) Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J 126:1068-1076
17. Masuko H, Jin MB, Horiuchi H, Suzuki T, Taniguchi M, Shimamura T, Fukai M, Magata S, Ogata K, Ishikawa H, Fujita M, Nagashima K, Furukawa H, Todo S (2001) Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation 71:1034-1039
18. Stenman E, Edvinsson L (2004) Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35:970-974
19. Timmermans V, Peake PW, Charlesworth JA, Macdonald GJ, Pawlak MA (1990) Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis. Kidney Int 38:518-524
20. Konstam MA (1995) Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodelling following myocardial infarction. Eur Heart J 16(Suppl K):42-48
21. Przyklenk K, Kloner RA (1993) Cardioprotection by ACE-inhibitors in acute myocardial ischemia and infarction. Basic Res Cardiol 88(Suppl 1):139-154
22. El Bekay R, Alvarez M, Monteseirin J, Alba G., Chacon P, Vega A, Martin-Nieto J, Jimenez J, Pintado E, Bedoya FJ, Sobrino F (2003) Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood 102:662-671
23. Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy D, Garg R (2003) Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab 88:4496-4501
24. Raiden S, Nahmod K, Nahmod V, Semeniuk G., Pereira Y, Alvarez C, Giordano M, Geffner JR (2002) Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther 303:45-51
25. Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355:637-645
26. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K (1993) Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H- tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116). J Pharmacol Exp Ther 266:114-120
27. Araya J, Tsuruma T, Hirata K, Yagihashi A (2002) Watanabe N TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats. Transplantation 73:529-534
28. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, Schulz R (2004) The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24:467-474
29. Groth W, Blume A, Gohlke P, Unger T, Culman J (2003) Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21:2175-2182
30. Takagi T, Yoshida N, Isozaki Y, Shimozawa M, Katada K, Manabe H, Hanada O, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T (2006) CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Eur J Pharmacol 535:283-290
31. Ohkawa H, Ohnishi N, Yagi K (1986) Assay for lipid peroxides for animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
32. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
33. Grisham MB, Hernandez LA, Granger DN (1986) Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251:G567-574
34. Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H (1989) The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem 264:19559-19563
35. Watanabe K, Suematsu M, Iida M, Takaishi K, Iizuka Y, Suzuki H, Suzuki M, Tsuchiya M, Tsurufuji S (1992) Effect of rat CINC/gro, a member of the interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol 56:60-69
36. Estelles R, Lopez-Martin J, Milian L, O'Connor JE, Martinez-Losa M, Cerda-Nicolas M, Anam EM, Ivorra MD, Issekutz AC, Cortijo J, Morcillo EJ, Blazquez MA, Sanz MJ (2003) Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo. Br J Pharmacol 140:1057-1067
37. Paragh G, Szabo J, Kovacs E, Keresztes T, Karpati I, Balogh Z, Pall D, Foris G (2002) Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolaemia. Cell Signal 14:787-792
38. Tsuruma T, Yagihashi A, Tarumi K, Hirata K (1998) Anti-rat IL-8 (CINC) monoclonal antibody administration reduces ischemia-reperfusion injury in small intestine. Transplant Proc 30:2644-2645
39. Yagihashi A, Tsuruma T, Tarumi K, Kameshima T, Yajima T, Yanai Y, Watanabe N, Hirata K (1998) Prevention of small intestinal ischemia-reperfusion injury in rat by anti-cytokine-induced neutrophil chemoattractant monoclonal antibody. J Surg Res 78:92-96
40. Nabah YN, Mateo T, Estelles R, Mata M, Zagorski J, Sarau H, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ (2004) Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 110:3581-3586